Caprock Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $14.5M | Sell |
29,997
-9,187
| -23% | -$4.45M | 0.44% | 40 |
|
|
2024
Q4 | $15.8M | Buy |
39,184
+1,096
| +3% | +$441K | 0.52% | 30 |
|
|
2024
Q3 | $17.7M | Buy |
38,088
+158
| +0.4% | +$73.5K | 0.64% | 24 |
|
|
2024
Q2 | $17.8M | Buy |
37,930
+35,045
| +1,215% | +$16.4M | 0.72% | 20 |
|
|
2024
Q1 | $1.21M | Buy |
2,885
+11
| +0.4% | +$4.6K | 0.07% | 211 |
|
|
2023
Q4 | $1.17M | Buy |
2,874
+306
| +12% | +$125K | 0.07% | 217 |
|
|
2023
Q3 | $893K | Buy |
2,568
+44
| +2% | +$15.3K | 0.07% | 234 |
|
|
2023
Q2 | $888K | Buy |
2,524
+257
| +11% | +$90.5K | 0.07% | 236 |
|
|
2023
Q1 | $714K | Sell |
2,267
-49
| -2% | -$15.4K | 0.06% | 268 |
|
|
2022
Q4 | $669K | Buy |
2,316
+152
| +7% | +$43.9K | 0.06% | 231 |
|
|
2022
Q3 | $627K | Buy |
2,164
+41
| +2% | +$11.9K | 0.06% | 232 |
|
|
2022
Q2 | $598K | Sell |
2,123
-1,241
| -37% | -$350K | 0.06% | 239 |
|
|
2022
Q1 | $878K | Sell |
3,364
-54
| -2% | -$14.1K | 0.08% | 198 |
|
|
2021
Q4 | $751K | Buy |
3,418
+1,955
| +134% | +$430K | 0.06% | 218 |
|
|
2021
Q3 | $265K | Sell |
1,463
-342
| -19% | -$61.9K | 0.02% | 417 |
|
|
2021
Q2 | $364K | Buy |
1,805
+325
| +22% | +$65.5K | 0.03% | 313 |
|
|
2021
Q1 | $318K | Sell |
1,480
-162
| -10% | -$34.8K | 0.03% | 318 |
|
|
2020
Q4 | $388K | Sell |
1,642
-452
| -22% | -$107K | 0.04% | 272 |
|
|
2020
Q3 | $570K | Buy |
2,094
+230
| +12% | +$62.6K | 0.08% | 185 |
|
|
2020
Q2 | $541K | Buy |
+1,864
| New | +$541K | 0.08% | 183 |
|